IT1170838B - STABLE CONCENTRATED SOLUTIONS OF CISPLATIN USEFUL AS PHARMACEUTICAL COMPOSITIONS AND RELATED PRODUCTION PROCESS - Google Patents

STABLE CONCENTRATED SOLUTIONS OF CISPLATIN USEFUL AS PHARMACEUTICAL COMPOSITIONS AND RELATED PRODUCTION PROCESS

Info

Publication number
IT1170838B
IT1170838B IT48090/81A IT4809081A IT1170838B IT 1170838 B IT1170838 B IT 1170838B IT 48090/81 A IT48090/81 A IT 48090/81A IT 4809081 A IT4809081 A IT 4809081A IT 1170838 B IT1170838 B IT 1170838B
Authority
IT
Italy
Prior art keywords
cisplatin
useful
pharmaceutical compositions
production process
concentrated solutions
Prior art date
Application number
IT48090/81A
Other languages
Italian (it)
Other versions
IT8148090A0 (en
Inventor
Murray A Kaplan
Alphonse P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8148090A0 publication Critical patent/IT8148090A0/en
Application granted granted Critical
Publication of IT1170838B publication Critical patent/IT1170838B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT48090/81A 1980-03-31 1981-03-24 STABLE CONCENTRATED SOLUTIONS OF CISPLATIN USEFUL AS PHARMACEUTICAL COMPOSITIONS AND RELATED PRODUCTION PROCESS IT1170838B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
IT8148090A0 IT8148090A0 (en) 1981-03-24
IT1170838B true IT1170838B (en) 1987-06-03

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48090/81A IT1170838B (en) 1980-03-31 1981-03-24 STABLE CONCENTRATED SOLUTIONS OF CISPLATIN USEFUL AS PHARMACEUTICAL COMPOSITIONS AND RELATED PRODUCTION PROCESS

Country Status (30)

Country Link
JP (1) JPS56152415A (en)
KR (1) KR860000841B1 (en)
AR (1) AR225500A1 (en)
AT (1) AT370996B (en)
AU (1) AU541056B2 (en)
BE (1) BE888209A (en)
CA (1) CA1162479A (en)
CH (1) CH647481A5 (en)
CS (1) CS246051B2 (en)
DD (1) DD157762A5 (en)
DE (1) DE3112272A1 (en)
DK (1) DK158564C (en)
ES (1) ES500869A0 (en)
FI (1) FI70670C (en)
FR (1) FR2480605A1 (en)
GB (1) GB2074028B (en)
GR (1) GR72769B (en)
HU (1) HU183379B (en)
IE (1) IE51070B1 (en)
IL (1) IL62517A (en)
IT (1) IT1170838B (en)
LU (1) LU83270A1 (en)
NL (1) NL8101531A (en)
NO (1) NO156675C (en)
NZ (1) NZ196519A (en)
PH (1) PH17152A (en)
PT (1) PT72774B (en)
SE (1) SE455045B (en)
SU (1) SU1056893A3 (en)
ZA (1) ZA812084B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (en) * 1982-09-23 1987-01-21 Erba Farmitalia PHARMACOLOGICAL COMPOSITIONS BASED ON CISPLATIN AND METHOD FOR THEIR OBTAINMENT
NL8303657A (en) * 1983-10-24 1985-05-17 Pharmachemie Bv SOLUTION, STABLE, AQUEOUS, AQUEOUS, CONTAINING SOLUTION OF CISPLATINE, AND METHOD OF PREPARING THEREOF.
FI895340A0 (en) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co HYPERTONISK CISPLATIN-LOESNING.
ES2208946T3 (en) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. LIPOSOMES CONTAINING A CISPLATIN COMPOUND.
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (en) 2004-03-26 2010-04-07 オンキヨー株式会社 Switching amplifier
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US11752135B2 (en) 2018-03-29 2023-09-12 Project Pharmaceutics Gmbh Liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
ATA150481A (en) 1982-10-15
IL62517A0 (en) 1981-05-20
ZA812084B (en) 1982-04-28
DD157762A5 (en) 1982-12-08
GB2074028A (en) 1981-10-28
AR225500A1 (en) 1982-03-31
AU6816681A (en) 1981-10-08
GB2074028B (en) 1983-09-21
LU83270A1 (en) 1981-10-29
NO156675C (en) 1987-11-04
NO156675B (en) 1987-07-27
IE51070B1 (en) 1986-09-17
IL62517A (en) 1984-01-31
DE3112272C2 (en) 1990-09-27
IE810715L (en) 1981-09-30
IT8148090A0 (en) 1981-03-24
AU541056B2 (en) 1984-12-13
PH17152A (en) 1984-06-13
FR2480605A1 (en) 1981-10-23
DE3112272A1 (en) 1982-04-29
AT370996B (en) 1983-05-25
ES8206545A1 (en) 1982-08-16
CA1162479A (en) 1984-02-21
NO811081L (en) 1981-10-01
DK158564B (en) 1990-06-11
KR860000841B1 (en) 1986-07-09
FR2480605B1 (en) 1984-05-11
PT72774A (en) 1981-04-01
KR830004849A (en) 1983-07-20
NL8101531A (en) 1981-10-16
CS246051B2 (en) 1986-10-16
HU183379B (en) 1984-04-28
FI70670C (en) 1986-10-06
SU1056893A3 (en) 1983-11-23
ES500869A0 (en) 1982-08-16
JPS6360008B2 (en) 1988-11-22
BE888209A (en) 1981-09-30
PT72774B (en) 1982-11-16
FI70670B (en) 1986-06-26
DK144281A (en) 1981-10-01
DK158564C (en) 1990-11-05
JPS56152415A (en) 1981-11-26
GR72769B (en) 1983-12-02
SE455045B (en) 1988-06-20
SE8101990L (en) 1981-11-13
CH647481A5 (en) 1985-01-31
FI810934L (en) 1981-10-01
NZ196519A (en) 1983-06-17

Similar Documents

Publication Publication Date Title
IT8122859A0 (en) DERIVATIVES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THEIR PREPARATION.
IT1116493B (en) INTERFERON PRODUCTION PROCESS AND COMPOSITIONS CONTAINING IT
IT1115800B (en) DERIVATIVES OF THE IMIDAZOLE RELATIVE PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT
IT1120977B (en) DERIVATIVES OF BOSSILIC PHENOXYLCALCAR ACIDS PARTICULARLY USEFUL AS MEDICATIONS
FR2358418A1 (en) NEW POLYGALACTOSIDOSACCHAROSES SULPHATES USEFUL IN PARTICULAR AS COMPLEMENT INHIBITORS
IT8423564A0 (en) DERIVATIVES OF 7-CARBOXYMETHOXY-FURO-(3,4-C)-PIRI DINA, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT1157014B (en) DERIVATIVES OF AMIDINOPIPERIDINE PARTICULARLY USEFUL AS MEDICATIONS AND PROCEDURE FOR THEIR PRODUCTION
IT1074295B (en) PROCEDURE FOR THE PREPARATION OF FUSIDIC ACID DERIVATIVES PARTICULARLY USEFUL AS BACTERIA CIDI
IT1170838B (en) STABLE CONCENTRATED SOLUTIONS OF CISPLATIN USEFUL AS PHARMACEUTICAL COMPOSITIONS AND RELATED PRODUCTION PROCESS
IT8322648A0 (en) DERIVATIVES OF 4-PHENYL4-OXO-BUTEN 2-OIC ACID, THEIR PREPARATION PROCEDURE AND THEIR APPLICATION AS MEDICINAL PRODUCTS.
IT8167382A0 (en) PROCEDURE FOR THE PREPARATION OF DIRECT YELLOW DYE 11 IN THE FORM OF STABLE CONCENTRATED SOLUTIONS SOLUTIONS OBTAINED AND THEIR APPLICATIONS
IT1251226B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CLOZAPINE, THEIR PREPARATION AND THEIR USE
IT8067888A0 (en) CARBOSTIRIL DERIVATIVES PARTICULARLY USEFUL AS MEDICINES AND PROCEDURE FOR THEIR PREPARATION
IT1174760B (en) 4-HYDROXY 3-QUINOLIN CARBOXYLIC ACID DERIVATIVES REPLACED IN 2, THEIR PREPARATION, THEIR APPLICATION AS MEDICATIONS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES OBTAINED
IT1161974B (en) CIS.I 2 EPOXYPROPYLPHOSPHONIC ACID DERIVATIVES THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE24716T1 (en) LENKOTRIAL ANTAGONISTS.
IT1228934B (en) DERIVATIVES OF 7-OXABICYCID ACID (2.2.1.) HYDROXAMIC EPTAN USEFUL AS DUPLIC INHIBITORS
FR2426683A1 (en) NEW 1,2,4-TRIAZOLIDIN-3-ONES OR -THIONES AND THEIR PREPARATION METHODS
IT8224755A0 (en) NEW DERIVATIVES OF PHENYLACETIC ACIDS, THEIR PREPARATION AND COMPOSITIONS THAT CONTAIN THEM.
IT8167391A0 (en) DERIVATIVES OF AMINO ACIDS PARTICULARLY USEFUL AS MEDICINES AND PROCEDURE FOR THEIR PREPARATION
IT8221373A0 (en) DERIVATIVES OF ARYL- AND HETERARYLMERCAPTO-ALKANIC ACID USEFUL AS ANTISEBORRHEA ADDITIVES FOR COSMETICS.
IT1164677B (en) 1,3 BENZODIOXY DERIVATIVES PROCEDURE FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE INCREDIENTS
IT7826520A0 (en) CITRIC ACID DERIVATIVES USEFUL AS SOFTENERS.
IT1157231B (en) MONOSUBSTITUTED DERIVATIVES OF 4-FENYL 4-BONE BUTEN-2-CICO ACID, USEFUL AS MEDICATIONS, AND THE COMPOSITIONS CONTAINING THEM
IT8224576A0 (en) DERIVATIVES OF AMINOPYRIDINCARBOXYLIC ACIDS, THEIR SYNTHESIS METHODS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM